On track to report topline data from Phase 2 TRANQUILITY trial in first half of 2025 – – Assembled Cardiovascular Scientific Advisory Board (CV SAB), comprised of leading academic and industry experts ...
Akero Therapeutics (AKRO) announced results of analyses supporting the clinical activity of efruxifermin in metabolic dysfunction-associated ...
Oral presentation shares head-to-head results for investigational combination pozelimab plus cemdisiran vs. ravulizumab in paroxysmal nocturnal hemoglobinuria Initial results for odronextamab in first ...
Mufasa: The Lion King's live-action poster has been reimagined in the classic style of the original Lion King's 2D art in a ...
Preparation is your stronghold, and yes, this is an obvious one, but it is also the leading cause of failed presentations. Beyond knowing your facts, delve into the nuances. Practice articulating your ...